呼吁欧洲肾脏照护协调统一:透析报销与肾脏替代治疗分布
结果显示,GDP较低的国家透析对公共卫生支出影响更大,PD与HD费用差异更小,家庭透析和肾移植提供更少。
要点
- 长期透析患病率每百万人口在GDP三分位间无显著差异(P=0.22)。
- PD比例随GDP三分位升高而增加(4.9%、8.2%、13.4%;P<0.001)。
- 最高GDP三分位国家HD与PD报销比更高(0.7、1.0 vs 1.7;P=0.007)。
核心结论
- 在欧洲,透析对公共卫生支出影响不成比例地高,尤其在GDP较低的国家。
- GDP较低国家PD与HD费用差异更小,家庭透析和肾移植提供频率低于高GDP国家。
研究设计与样本
- 欧洲国家按人均国内生产总值(GDP)三分位分类,报销数据与肾脏替代治疗(KRT)数据匹配。
主要发现
- 长期透析每百万人口患病率在GDP三分位间无显著差异(P=0.22)。
- PD百分比随GDP三分位升高而增加(4.9、8.2、13.4%;P<0.001)。
- HD与PD报销比在最高GDP三分位国家更高(0.7、1.0 vs 1.7;P=0.007)。
- 家庭HD主要在最高GDP三分位国家报销(15、15 vs 69%;P=0.005)。
- 透析报销占公共卫生支出百分比随GDP三分位升高而下降(3.3、1.5、0.7%;P<0.001)。
临床怎么用
- GDP较低国家可考虑优化报销策略以缩小PD与HD费用差异,并促进家庭透析和肾移植。
- 需深入评估经济和政治措施,以引导肾脏替代治疗报销策略优化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We compare reimbursement for haemodialysis (HD) and peritoneal dialysis (PD) in European countries to assess the impact on government healthcare budgets. We discuss strategies to reduce costs by promoting sustainable dialysis and kidney transplantation. METHODS: This was a cross-sectional survey among nephrologists conducted online July-December 2016. European countries were categorized by tertiles of gross domestic product per capita (GDP). Reimbursement data were matched to kidney replacement therapy (KRT) data. RESULTS: The prevalence per million population of patients being treated with long-term dialysis was not significantly different across tertiles of GDP (P = 0.22). The percentage of PD increased with GDP across tertiles (4.9, 8.2, 13.4%; P < 0.001). The HD-to-PD reimbursement ratio was higher in countries with the highest tertile of GDP (0.7, 1.0 versus 1.7; P = 0.007). Home HD was mainly reimbursed in countries with the highest tertile of GDP (15, 15 versus 69%; P = 0.005). The percentage of public health expenditure for reimbursement of dialysis decreased across tertiles of GDP (3.3, 1.5, 0.7%; P < 0.001). Transplantation as a proportion of all KRT increased across tertiles of GDP (18.5, 39.5, 56.0%; P < 0.001). CONCLUSIONS: In Europe, dialysis has a disproportionately high impact on public health expenditure, especially in countries with a lower GDP. In these countries, the cost difference between PD and HD is smaller, and home dialysis and transplantation are less frequently provided than in countries with a higher GDP. In-depth evaluation and analysis of influential economic and political measures are needed to steer optimized reimbursement strategies for KRT.
引用
- van der Tol A, Stel VS, Jager KJ, et al. A call for harmonization of European kidney care: dialysis reimbursement and distribution of kidney replacement therapies. Nephrol Dial Transplant. 2020. PMID: 32227227. doi:10.1093/ndt/gfaa035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。